Mini-symposium: New precision medicine tools for hormone dependent cancers

April 9th 13.30-15.30, Medicon Village, Allvar lecture hall

Coffee and fika will be served

• Gene expression classifiers for tailored breast cancer radiotherapy

• Novel liquid biopsy technology for advanced prostate cancer

• Multimodal AI treatment response prediction for prostate and other cancers


Dr. Laura Chang, PhD, Vice President, Artera AI, San Francisco, CA, USA

Dr. Shuang G. Zhao, MD, Assistant Professor and co-director of the liquid biopsy core

University of Wisconsin, Madison, WI, USA


Martin Sjöström, MD, PhD, LUCC